April 2025 FDA Recall Chlorpromazine Hydrochloride by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
D-0366-2025 - CGMP deviations

This Class II drug recall was voluntarily initiated by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories on April 14, 2025 for the product Chlorpromazine Hydrochloride. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0366-2025

Reason for Recall
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
Initiated
04-14-2025
Reported
04-23-2025
Quantity
133 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7129-61

Batch or Lot Expiration Information

Lot# : N02114, Exp 12/31/2025